Scinovex
article Open AccessTop 1% cited

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

The Journal of Urology · 2009 · Vol. 181(3) · pp. 956–962
Ian M. ThompsonCatherine M. TangenJorge C. ParadeloM. Scott LuciaGary J. MillerDean A. TroyerEdward M. MessingJeffrey D. FormanJoseph L. ChinGregory P. SwansonEdith Canby‐HaginoE. David Crawford

Abstract

Adjuvant radiotherapy after radical prostatectomy for a man with pT3N0M0 prostate cancer significantly reduces the risk of metastasis and increases survival.

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentHepatocellular Carcinoma Treatment and PrognosisMedicineRadiation therapyProstate cancerProstatectomyRandomized controlled trialOncologyInternal medicineMetastasisAdjuvantClinical endpoint
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.